0.5400
-0.0240
(-4.26%)
At close: January 10 at 4:50:54 PM GMT+1
Key Executives
Amounts are as of December 31, 2023 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in SEK.
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Dr. Peder Moller Andersen M.D. | Chief Medical Officer | 1.62M | -- | 1952 |
| Ms. Tine Kold Olesen Ph.D. | CEO & Member of Executive Board | -- | -- | -- |
| Mr. Niels Laursen M.B.A. | Chief Financial Officer | -- | -- | 1956 |
| Mr. Sergey B. Zotchev Ph.D. | Chief Scientific Officer and Member of Scientific Advisory Panel | -- | -- | -- |
Biosergen AB
Fogdevreten 2
Solna, 171 65
Sweden
- Sector:
- Healthcare
- Industry: Biotechnology
- Full Time Employees:
- 2
Description
Biosergen AB, a biotech company, develops antifungal products. It is developing BSG005, an antifungal drug candidate for the treatment of fungal infections. The company was founded in 2004 and is based in Solna, Sweden.
Corporate Governance
Biosergen AB’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Upcoming Events
Upcoming Events Information Not Available
Recent Events
Recent Events Information Not Available
Related Tickers
ATORX.ST Alligator Bioscience AB (publ)
0.2290
+2.46%
2CUREX.ST 2cureX AB (publ)
0.4200
0.00%
XBRANE.ST Xbrane Biopharma AB (publ)
0.1568
-3.80%
8GN.F Cessatech A/S
1.4650
+1.38%
PCIB.OL PCI Biotech Holding ASA
1.3000
0.00%
LIDDS.ST LIDDS AB (publ)
0.1500
-6.25%
NANECH.ST NanoEcho AB
0.2025
-1.46%
XSPRAY.ST Xspray Pharma AB (publ)
29.25
-15.34%
COMBI.ST CombiGene AB (publ)
2.5200
+2.44%
ACTI.ST Active Biotech AB (publ)
0.1130
-3.09%